Daiichi Sankyo poised to add another ADC blockbuster with datopotamab deruxtecan for non-squamous NSCLC: GlobalData Read more
AstraZeneca’s Tagrisso to lead lung cancer small molecule market with over $7 bn sales by 2029: GlobalData Read more
European Commission approves Roche’s Gavreto to treat adults with RET fusion-positive advanced non-small cell lung cancer Read more
US FDA nod for Roche’s VENTANA ALK (D5F3) CDx assay as companion diagnostic for NSCLC treatment with LORBRENA Read more
Pfizer gets full US FDA nod for LORBRENA as first-line treatment for ALK-Positive metastatic NSCLC Read more